Skip to content

Clinical study on the effect of glycerol fructose on cerebral edema and clinical efficacy in patients with small amount of intracerebral hemorrhage

Clinical study on the effect of glycerol fructose on cerebral edema and clinical efficacy in patients with small amount of intracerebral hemorrhage

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039923
Enrollment
Unknown
Registered
2020-11-14
Start date
2020-12-01
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracerebral hemorrhage

Interventions

Experimental group: glycerin fructose
Control group:conventional treatment

Sponsors

Tianjin First Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. According to the clinical manifestations and signs, combined with brain CT, MRI and other related examinations, the patients with cerebral hemorrhage were definitely diagnosed; 2. Patients with supratentorial intracerebral hemorrhage who were admitted to hospital within 12 hours after onset and whose blood loss was less than 20 ml according to imaging data and were not ruptured into ventricle; 3. All the patients without severe neurological deficit and disturbance of consciousness have indications for conservative treatment.

Exclusion criteria

Exclusion criteria: 1. Intracranial space occupying patients; 2. Patients with severe systemic infection, immune dysfunction, blood diseases and other serious diseases; 3. In the course of treatment, those patients with increased cerebral hemorrhage need surgical treatment; 4. Those patients who need further dehydration treatment for the occurrence of severe brain edema.

Design outcomes

Primary

MeasureTime frame
Hematoma volume and brain edema volume;

Countries

China

Contacts

Public ContactLu Hongwei

Department of Neurosurgery, Tianjin First Central Hospital

luhongwei171@qq.com+86 18322617817

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026